Back
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Vs. Neurogene Industry Stock Comparison
Sell
45
CHAU
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF
Last Price:
16.29
Seasonality Move:
9.03%
Buy
75
NGNE
Neurogene
Last Price:
65.96
Seasonality Move:
58.98%
Sell
45
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF (CHAU)
is a Sell
Is Direxion Dly CSI 300 CHN A Shr Bl 2X ETF a Buy, Sell or Hold?
- The current Direxion Dly CSI 300 CHN A Shr Bl 2X ETF [CHAU] share price is $16.29. The Score for CHAU is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CHAU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Neurogene (NGNE)
is a Buy
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CHAU Stock Price Chart
What is Direxion Dly CSI 300 CHN A Shr Bl 2X ETF's stock price today?
-
The Direxion Dly CSI 300 CHN A Shr Bl 2X ETF share price today is $16.29
The current trend is relatively stagnant and CHAU is experiencing selling pressure, which indicates risk of future bearish movement.
NGNE Stock Price Chart
CHAU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 49.7 | Sell |
Chaikin Money Flow: | -692322 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.76 - 20.92) | Sell |
Bollinger Bands (100): | (11.4 - 16.94) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.06 | Buy |
Relative Strength Index (14 RSI): | 75.97 | Buy |
Chaikin Money Flow: | 176225 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.28 - 53.36) | Buy |
Bollinger Bands (100): | (34.64 - 46.72) | Buy |
CHAU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.14 | Buy |
20-day SMA: | 16.53 | Sell |
50-day SMA: | 15.32 | Buy |
200-day SMA: | 14.04 | Buy |
8-day EMA: | 16.16 | Buy |
20-day EMA: | 16.43 | Sell |
50-day EMA: | 15.74 | Buy |
200-day EMA: | 14.76 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.43 | Buy |
20-day SMA: | 49.56 | Buy |
50-day SMA: | 43.32 | Buy |
200-day SMA: | 37.93 | Buy |
8-day EMA: | 50.65 | Buy |
20-day EMA: | 48.54 | Buy |
50-day EMA: | 44.96 | Buy |
200-day EMA: | 36.96 | Buy |
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Earnings Growth & CHAU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Direxion Dly CSI 300 CHN A Shr Bl 2X ETF Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |